索菲亞(002572.SZ):批准湖北索菲亞實施櫃類項目擴產計劃
格隆匯6月17日丨索菲亞(002572.SZ)公佈,公司第五屆第七次會議審議通過了《關於全資子公司索菲亞家居湖北有限公司投資建設擴產項目的議案》,批准索菲亞家居湖北有限公司(“湖北索菲亞”)實施索菲亞櫃類項目擴產計劃,擴產計劃規劃總投入為8億元;董事會授權管理層根據政策情況、市場變化和經營發展需要,逐步分階段推進擴產計劃的項目規劃、建設和投產,並在項目規劃總投資範圍內動態調整建設週期和實際投資總額,以及辦理、簽署擴產項目涉及的相關手續與文件。
該項目規劃建設年產35.2萬套定製櫃類及配套家居產品,其中包括櫃身、櫃門、門類、吸塑以及油漆產品等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.